Repligen | القيمة السوقية

Market Capitalization تغيير تاريخ
Agilent USD 40.74B 8.02B 2023-12
Align Technology USD 20.99B 2.38B 2023-12
Bio Techne USD 11.13B 1.07B 2024-03
BioMarin Pharmaceutical USD 18.16B 1.51B 2023-12
Bristol-Myers Squibb USD 104.4B 16.85B 2023-12
Bruker USD 10.17B 1.02B 2023-12
Catalent USD 8.12B 92M 2023-12
Charles River Laboratories USD 12.13B 2.08B 2023-12
Danaher USD 170.94B 12.24B 2023-12
Dentsply International USD 6.97B 571M 2024-03
Exact Sciences USD 13.38B 3.56B 2023-12
General Electric USD 138.91B 18.59B 2023-12
Henry Schein USD 9.4B 440M 2024-03
Illumina USD 21.33B 781M 2024-03
IQVIA Holdings USD 45.83B 3.6B 2024-03
Mettler Toledo International USD 28.32B 2.01B 2024-03
Myriad Genetics USD 1.99B 294M 2024-03
NanoString Technologies USD 4M 32M 2024-03
OraSure Technologies USD 435M 68M 2023-09
Pacific Biosciences Of California USD 2.62B 532M 2023-12
Patterson Companies USD 2.44B 196M 2024-03
Peregrine Pharmaceuticals USD 424M 13M 2024-03
Pfizer USD 155.51B 7.05B 2024-03
Repligen USD 11.12B 1.08B 2024-03
Revvity USD 12.73B 765M 2024-03
Standard Biotools USD 177M 52M 2023-12
Thermo Fisher Scientific USD 222.03B 16.95B 2024-03
Waters USD 20.39B 923M 2024-03
West Pharmaceutical Services USD 28.76B 2.71B 2024-03



Repligen القيمة السوقية - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Apr 2024.